scholarly article | Q13442814 |
P356 | DOI | 10.2217/PGS-2017-0040 |
P698 | PubMed publication ID | 28841113 |
P50 | author | Cynthia Marie-Claire | Q57698362 |
Frank Bellivier | Q56479996 | ||
Florence Vorspan | Q42907302 | ||
P2093 | author name string | Jean-Pierre Lépine | |
Vanessa Bloch | |||
Clément Jourdaine | |||
P2860 | cites work | ABCB1 and cytochrome P450 genotypes and phenotypes: Influence on methadone plasma levels and response to treatment | Q57550258 |
Epigenetic mechanisms of drug addiction | Q22251252 | ||
Buprenorphine: a unique drug with complex pharmacology | Q24642980 | ||
MicroRNAs as biomarkers for CNS disease | Q27013998 | ||
Individual differences in gene expression of vasopressin, D2 receptor, POMC and orexin: vulnerability to relapse to heroin-seeking in rats | Q27304542 | ||
Upregulation of SOCS-3 and PIAS-3 Impairs IL-12-Mediated Interferon-Gamma Response in CD56+ T Cells in HCV-Infected Heroin Users | Q27491026 | ||
Hat2p recognizes the histone H3 tail to specify the acetylation of the newly synthesized H3/H4 heterodimer by the Hat1p/Hat2p complex | Q27683819 | ||
Chromatin modifications and their function | Q27861067 | ||
MicroRNA in Control of Gene Expression: An Overview of Nuclear Functions | Q28080201 | ||
Genome-Wide Association of Heroin Dependence in Han Chinese | Q28554877 | ||
Functions of DNA methylation: islands, start sites, gene bodies and beyond | Q29547260 | ||
Repression of protein synthesis by miRNAs: how many mechanisms? | Q29620361 | ||
Transgenerational epigenetic inheritance in mammals: how good is the evidence? | Q30251679 | ||
Association between the DRD2 A1 allele and response to methadone and buprenorphine maintenance treatments | Q33238415 | ||
Chromatin-modifying and -remodeling complexes | Q33632339 | ||
Is human blood a good surrogate for brain tissue in transcriptional studies? | Q33723516 | ||
Mechanisms of epigenetic memory | Q33810523 | ||
Contribution of cytochrome P450 and ABCB1 genetic variability on methadone pharmacokinetics, dose requirements, and response | Q33903933 | ||
Pharmacotherapy in the treatment of addiction: methadone | Q33914167 | ||
Evidence-based treatment for opioid disorders: a 23-year national study of methadone dose levels | Q34069882 | ||
MicroRNAs: master regulators of ethanol abuse and toxicity? | Q34078032 | ||
Genome-wide association study identifies genes that may contribute to risk for developing heroin addiction | Q34118780 | ||
The relationship between primary prescription opioid and buprenorphine-naloxone induction outcomes in a prescription opioid dependent sample | Q34119478 | ||
Up-regulation of microRNAs in brain of human alcoholics | Q34190564 | ||
Proton-coupled hole hopping in nucleosomal and free DNA initiated by site-specific hole injection | Q34242651 | ||
Dysregulated postsynaptic density and endocytic zone in the amygdala of human heroin and cocaine abusers | Q34473458 | ||
Altered microRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder | Q34571298 | ||
Methadone induces CAD degradation and AIF-mediated necrotic-like cell death in neuroblastoma cells. | Q34625707 | ||
Increased OPRM1 DNA methylation in lymphocytes of methadone-maintained former heroin addicts | Q34656790 | ||
Regulation of nonphosphorylated and phosphorylated forms of neurofilament proteins in the prefrontal cortex of human opioid addicts | Q44332350 | ||
ABCB1 genetic variability and methadone dosage requirements in opioid-dependent individuals | Q44333294 | ||
Demethylation regulation of BDNF gene expression in dorsal root ganglion neurons is implicated in opioid-induced pain hypersensitivity in rats | Q44335797 | ||
Chronic opioid use is associated with increased DNA methylation correlating with increased clinical pain | Q44337324 | ||
Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment | Q44339701 | ||
Pharmacoepigenetics of the role of DNA methylation in μ-opioid receptor expression in different human brain regions | Q44340444 | ||
Decreased immunodensities of micro-opioid receptors, receptor kinases GRK 2/6 and beta-arrestin-2 in postmortem brains of opiate addicts | Q44344535 | ||
Alteration of lymphocyte opioid receptors in methadone maintenance subjects | Q44344561 | ||
Regulation of immunolabelled mu-opioid receptors and protein kinase C-alpha and zeta isoforms in the frontal cortex of human opiate addicts | Q44345799 | ||
β-Arrestin2 influences the response to methadone in opioid-dependent patients. | Q44346717 | ||
Effect of chronic heroin and cocaine administration on global DNA methylation in brain and liver. | Q44521498 | ||
Gender differences in prevalence of substance use disorders among individuals with lifetime exposure to substances: results from a large representative sample | Q44588941 | ||
Brain penetration of methadone (R)- and (S)-enantiomers is greatly increased by P-glycoprotein deficiency in the blood-brain barrier of Abcb1a gene knockout mice | Q44719752 | ||
Histone H3 phosphoacetylation is critical for heroin-induced place preference | Q45249049 | ||
Expression levels of the BDNF gene and histone modifications around its promoters in the ventral tegmental area and locus ceruleus of rats during forced abstinence from morphine | Q45699084 | ||
Increased locomotor activity induced by heroin in mice: pharmacokinetic demonstration of heroin acting as a prodrug for the mediator 6-monoacetylmorphine in vivo. | Q45960896 | ||
Epigenetic regulation and gene expression of vasopressin and atrial natriuretic peptide in alcohol withdrawal | Q46220739 | ||
Morphine causes a delayed increase in glutamate receptor functioning in the nucleus accumbens core | Q46390279 | ||
Alpha-synuclein protein levels are increased in alcoholic patients and are linked to craving | Q46493884 | ||
Promoter specific methylation of the dopamine transporter gene is altered in alcohol dependence and associated with craving. | Q46574866 | ||
Family and environmental factors of drug addiction among young recruits | Q46712211 | ||
CB1 and CB2 receptor expression and promoter methylation in patients with cannabis dependence | Q46825133 | ||
Childhood trauma are not associated with the intensity of transient cocaine induced psychotic symptoms | Q47678999 | ||
Elevated methylation and decreased serum concentrations of BDNF in patients in levomethadone compared to diamorphine maintenance treatment | Q48065707 | ||
The influence of heroin abuse on glutathione-dependent enzymes in human brain | Q48089749 | ||
Morphine withdrawal produces ERK-dependent and ERK-independent epigenetic marks in neurons of the nucleus accumbens and lateral septum. | Q48195741 | ||
Okadaic acid blocks the effects of 5-aza-2-deoxycytidine on consolidation, acquisition and retrieval of morphine-induced place preference in rats | Q48594952 | ||
Evaluating the comparability of gene expression in blood and brain | Q48623627 | ||
Increased serum brain-derived neurotrophic factor levels during opiate withdrawal | Q48785111 | ||
Inhibition of histone deacetylase in the basolateral amygdala facilitates morphine context-associated memory formation in rats. | Q50662543 | ||
Impact of P-glycoprotein at the blood-brain barrier on the uptake of heroin and its main metabolites: behavioral effects and consequences on the transcriptional responses and reinforcing properties. | Q50672428 | ||
CYP2B6 polymorphisms influence the plasma concentration and clearance of the methadone S-enantiomer. | Q50797242 | ||
Comparison of the transcriptional responses induced by acute morphine, methadone and buprenorphine. | Q51035649 | ||
Problem drinking in relation to treatment outcome among opiate addicts in methadone maintenance treatment. | Q51761037 | ||
Screening for illicit heroin use in patients in a heroin-assisted treatment program. | Q52289783 | ||
Association of CYP2D6 ultrarapid metabolizer genotype with deficient patient satisfaction regarding methadone maintenance treatment. | Q52290614 | ||
Effect of the histone deacetylase inhibitors on behavioural sensitization to a single morphine exposure in mice. | Q52298317 | ||
Temperament and character modify risk of drug addiction and influence choice of drugs. | Q52301332 | ||
Variability of response to methadone: genome-wide DNA methylation analysis in two independent cohorts. | Q52308504 | ||
Methylation analysis of circadian clock gene promoters in forensic autopsy specimens. | Q54372154 | ||
Epigenetic DNA hypermethylation of the HERP gene promoter induces down-regulation of its mRNA expression in patients with alcohol dependence. | Q54611266 | ||
Inhibition of anti-HIV microRNA expression: a mechanism for opioid-mediated enhancement of HIV infection of monocytes | Q34756351 | ||
Substance-specific and shared transcription and epigenetic changes in the human hippocampus chronically exposed to cocaine and alcohol | Q34836140 | ||
Prefrontal cortex plasticity mechanisms in drug seeking and relapse | Q35014177 | ||
Nerve growth factor β polypeptide (NGFB) genetic variability: association with the methadone dose required for effective maintenance treatment | Q35087543 | ||
Electrocardiographic effects of lofexidine and methadone coadministration: secondary findings from a safety study. | Q35147971 | ||
MicroRNA expression is differentially altered by xenobiotic drugs in different human cell lines. | Q35171243 | ||
Maternal cannabis use alters ventral striatal dopamine D2 gene regulation in the offspring | Q35269497 | ||
Differential activation of G-proteins by mu-opioid receptor agonists | Q35545366 | ||
Gene expression in the addicted brain | Q35592193 | ||
Epigenetic modulation of brain gene networks for cocaine and alcohol abuse. | Q35626140 | ||
Heroin use promotes HCV infection and dysregulates HCV-related circulating microRNAs | Q35650384 | ||
Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity | Q35684822 | ||
Alterations in serum microRNA in humans with alcohol use disorders impact cell proliferation and cell death pathways and predict structural and functional changes in brain | Q35765140 | ||
Within- and between- subject variability in methadone pharmacokinetics and pharmacodynamics in methadone maintenance subjects | Q35826959 | ||
Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments | Q36056325 | ||
Morphine-induced changes of gene expression in the brain | Q36105247 | ||
Pharmacophore-based discovery of inhibitors of a novel drug/proton antiporter in human brain endothelial hCMEC/D3 cell line | Q36211219 | ||
Cigarette smoking reduces DNA methylation levels at multiple genomic loci but the effect is partially reversible upon cessation | Q36216466 | ||
Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood | Q36245292 | ||
Heroin inhibits HIV-restriction miRNAs and enhances HIV infection of macrophages | Q36245718 | ||
Neuroplasticity, axonal guidance and micro-RNA genes are associated with morphine self-administration behavior | Q36335668 | ||
Quantification of plasma microRNAs in a group of healthy smokers, ex-smokers and non-smokers and correlation to biomarkers of tobacco exposure | Q36357339 | ||
Opioid neuropeptide genotypes in relation to heroin abuse: dopamine tone contributes to reversed mesolimbic proenkephalin expression | Q36393054 | ||
Epigenetics of Stress, Addiction, and Resilience: Therapeutic Implications | Q36437440 | ||
ABCB1 haplotype and OPRM1 118A > G genotype interaction in methadone maintenance treatment pharmacogenetics | Q36441533 | ||
Treatment retention in adolescent patients treated with methadone or buprenorphine for opioid dependence: a file review | Q36454768 | ||
Roles of nucleus accumbens CREB and dynorphin in dysregulation of motivation | Q36554599 | ||
Gene coexpression networks in human brain identify epigenetic modifications in alcohol dependence | Q36587882 | ||
Distinctive Roles of 5-aza-2'-deoxycytidine in Anterior Agranular Insular and Basolateral Amygdala in Reconsolidation of Aversive Memory Associated with Morphine in Rats | Q36685797 | ||
Alcohol Use During Pregnancy is Associated with Specific Alterations in MicroRNA Levels in Maternal Serum | Q36780087 | ||
Identification of long noncoding RNAs dysregulated in the midbrain of human cocaine abusers | Q36795258 | ||
Dopamine receptor D1 and postsynaptic density gene variants associate with opiate abuse and striatal expression levels | Q36798293 | ||
Global DNA promoter methylation in frontal cortex of alcoholics and controls. | Q36842272 | ||
MiR-582-5p/miR-590-5p targeted CREB1/CREB5-NF-κB signaling and caused opioid-induced immunosuppression in human monocytes | Q36915560 | ||
ABCB1 (MDR1) genetic variants are associated with methadone doses required for effective treatment of heroin dependence | Q37008505 | ||
Ethnic diversity of DNA methylation in the OPRM1 promoter region in lymphocytes of heroin addicts | Q37084865 | ||
Impact of treatment for opioid dependence on fatal drug-related poisoning: a national cohort study in England | Q37106422 | ||
Search for genetic markers and functional variants involved in the development of opiate and cocaine addiction and treatment | Q37160674 | ||
Association of genetic variation in pharmacodynamic factors with methadone dose required for effective treatment of opioid addiction | Q37401604 | ||
The implications of medication development in the treatment of substance use disorders in developing countries. | Q37433717 | ||
Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial | Q37625536 | ||
Genome-wide association study of opioid dependence: multiple associations mapped to calcium and potassium pathways | Q37711041 | ||
Let-7 microRNAs and Opioid Tolerance | Q38022011 | ||
An integrated quantitative proteomics and systems biology approach to explore synaptic protein profile changes during morphine exposure | Q38138785 | ||
What has been achieved in HIV prevention, treatment and care for people who inject drugs, 2010-2012? A review of the six highest burden countries | Q38151439 | ||
Impact of ABCB1 and CYP2B6 genetic polymorphisms on methadone metabolism, dose and treatment response in patients with opioid addiction: a systematic review and meta-analysis | Q38184547 | ||
Chromatin dynamics: interplay between remodeling enzymes and histone modifications | Q38192410 | ||
Novel types and sites of histone modifications emerge as players in the transcriptional regulation contest | Q38249060 | ||
Principles of miRNA-mRNA interactions: beyond sequence complementarity | Q38513793 | ||
Epigenetic Mechanisms of Psychostimulant-Induced Addiction | Q38526694 | ||
Lateral Thinking: How Histone Modifications Regulate Gene Expression | Q38679432 | ||
The Need for Treatment Responsive Translational Biomarkers in Alcoholism Research | Q38848288 | ||
DNMT inhibitors reverse a specific signature of aberrant promoter DNA methylation and associated gene silencing in AML | Q38947913 | ||
Interplay between the miRNome and the epigenetic machinery: Implications in health and disease. | Q39098623 | ||
μ opioid receptor agonist-selective regulation of interleukin-4 in T lymphocytes | Q39363573 | ||
Serum levels of BDNF are associated with craving in opiate-dependent patients. | Q39479692 | ||
DNA methylation has a local effect on transcription and histone acetylation | Q39675456 | ||
Interaction of drugs of abuse and maintenance treatments with human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2). | Q39779618 | ||
Valproic acid sodium inhibits the morphine-induced conditioned place preference in the central nervous system of rats. | Q40168982 | ||
The effect of baseline cocaine use on treatment outcomes for heroin dependence over 24 months: findings from the Australian Treatment Outcome Study | Q40171406 | ||
Real-time assessment of alcohol drinking and drug use in opioid-dependent polydrug users | Q41633643 | ||
Morphine epigenomically regulates behavior through alterations in histone H3 lysine 9 dimethylation in the nucleus accumbens | Q42393444 | ||
The SUMMIT trial: a field comparison of buprenorphine versus methadone maintenance treatment. | Q42917548 | ||
Lifetime multiple substance use pattern among heroin users before entering methadone maintenance treatment clinic in Yunnan, China | Q42968271 | ||
Diversion and injection of methadone and buprenorphine among clients in public opioid treatment clinics in New South Wales, Australia | Q43213071 | ||
Selective boosting of transcriptional and behavioral responses to drugs of abuse by histone deacetylase inhibition. | Q43281713 | ||
The effects of opioid peptides on dopamine release in the nucleus accumbens: an in vivo microdialysis study | Q43695146 | ||
A national study of the retention of Irish opiate users in methadone substitution treatment | Q43706695 | ||
Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis | Q43884128 | ||
P577 | publication date | 2017-08-25 | |
P1433 | published in | Pharmacogenomics | Q15724625 |
P1476 | title | Pharmacoepigenomics of opiates and methadone maintenance treatment: current data and perspectives |